lifestyle.successfuldaily.com

Author: Disc Medicine Inc

Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting

April 21, 2026
Disc Medicine to Participate in Upcoming Investor Conferences

February 24, 2026
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP

February 13, 2026